These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22577909)

  • 41. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
    Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM; Wang JT; Weng CM; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):346-51. PubMed ID: 21524980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
    Efe S; Sinirtaş M; Ozakin C
    Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.
    Whitehouse T; Cepeda JA; Shulman R; Aarons L; Nalda-Molina R; Tobin C; MacGowan A; Shaw S; Kibbler C; Singer M; Wilson AP
    J Antimicrob Chemother; 2005 Mar; 55(3):333-40. PubMed ID: 15705641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparative study of the susceptibility to daptomycin and other antimicrobials against Staphylococcus spp. resistant to methicillin and Enterococcus spp. using Wider, E-test, and microdilution methods].
    Gómez-Garcés JL; López-Fabal F; Burillo A; Gil Y
    Rev Esp Quimioter; 2010 Jun; 23(2):87-92. PubMed ID: 20559607
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
    Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
    Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperbaric oxygen as adjunctive therapy in experimental mediastinitis.
    Turhan V; Sacar S; Uzun G; Sacar M; Yildiz S; Ceran N; Gorur R; Oncul O
    J Surg Res; 2009 Jul; 155(1):111-5. PubMed ID: 19181335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
    Luther MK; LaPlante KL
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in China.
    Wang H; Liu Y; Sun H; Xu Y; Xie X; Chen M
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):226-9. PubMed ID: 18653301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
    Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of linezolid, teicoplanin, and vancomycin in prevention of an experimental polytetrafluoroethylene graft infection model caused by methicillin-resistant Staphylococcus aureus.
    Mese B; Bozoglan O; Elveren S; Eroglu E; Gul M; Celik A; Ciralik H; Yildirimdemir HI; Yasim A
    Med Sci Monit; 2015 Mar; 21():909-14. PubMed ID: 25819685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poor removal of tedizolid during continuous hemodiafiltration: experiments using an in vitro continuous hemodiafiltration model.
    Yoshikawa S; Yoshikawa S; Sato A; Matsumoto T
    J Pharm Health Care Sci; 2023 Nov; 9(1):37. PubMed ID: 37957772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
    Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
    Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
    Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
    Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetic and pharmacodynamic analyses of teicoplanin in Japanese patients with systemic MRSA infection.
    Ogawa R; Kobayashi S; Sasaki Y; Makimura M; Echizen H
    Int J Clin Pharmacol Ther; 2013 May; 51(5):357-66. PubMed ID: 23458228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Penetration of linezolid into rabbit intervertebral discs and surrounding tissues.
    Komatsu M; Takahata M; Sugawara M; Takekuma Y; Kato T; Ito M; Abe Y; Irie T; Iwasaki N; Minami A
    Eur Spine J; 2010 Dec; 19(12):2149-55. PubMed ID: 20694846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of factors associated with the achievement of an optimal teicoplanin trough concentration
.
    Takechi K; Yanagawa H; Zamami Y; Ishizawa K; Tanaka A; Araki H
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):672-677. PubMed ID: 28655381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.